While the UK government has cleared Pfizer-BioNTech's mRNA vaccine for use in public, the same is unlikely to be available anytime soon in India.
For one, US giant Pfizer’s India arm has not yet applied for conducting clinical trials here, according to sources, and secondly, the vaccine has stringent temperature requirements (-75 degree Celsius), which make it unviable for cold-chain logistics in India.
A government official in the know indicated that Pfizer has not yet applied for holding clinical trials on Indian volunteers, as is a pre-requisite for the regulator here to give authorisation to a particular investigational
For one, US giant Pfizer’s India arm has not yet applied for conducting clinical trials here, according to sources, and secondly, the vaccine has stringent temperature requirements (-75 degree Celsius), which make it unviable for cold-chain logistics in India.
A government official in the know indicated that Pfizer has not yet applied for holding clinical trials on Indian volunteers, as is a pre-requisite for the regulator here to give authorisation to a particular investigational